Honda Side Airbag Problems Prompt NHTSA Investigation Amid Injury Reports

Honda Side Airbag Investigation Opened Following Injury Reports NHTSA

More than 441,000 Honda Odyssey vehicles are under federal investigation following reports that side airbags have deployed unexpectedly, posing a potential risk of injury or collision.

The U.S. National Highway Traffic Safety Administration (NHTSA) announced the Honda side airbag investigation on October 28, after receiving reports of problems with the side airbags inflating without warning while vehicles were in motion, often after hitting a bump, uneven pavement or other surface irregularities.

Side airbags are designed to deploy along the sides of a vehicle’s seats or doors during a side-impact crash, creating a protective barrier between occupants and the interior panels, glass or incoming objects. In the Honda Odyssey, these airbags help reduce the risk of head, chest and pelvic injuries by cushioning the force of impact during a collision.

When these airbags deploy unexpectedly, however, they can strike occupants with significant force and startle the driver, increasing the likelihood of losing control of the vehicle. Sudden inflation could also obstruct the driver’s view or attention, raising the risk of an accident even in otherwise normal driving conditions.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

NHTSA’s Office of Defects Investigation (ODI) resume (PDF) indicates that the manufacturer has received at least 18 complaints regarding the issue, including two reports of injuries.

Federal regulators have launched a preliminary evaluation targeting 441,002 Honda Odyssey minivans from model years 2018 through 2022 to assess the scope and seriousness of the potential safety hazard.

Rear Seatbelt Investigation

On the same day it announced the side airbag probe, NHTSA also opened an investigation into the rear seatbelt warning system in certain Honda Pilot SUVs. The system is designed to alert drivers when passengers in the back seats are not properly buckled, helping ensure everyone remains secured during a crash.

However, inaccurate seatbelt alerts may cause drivers to believe rear passengers are safely restrained when they are not, or lead occupants to ignore the warnings altogether. This raises particular safety concerns for children and others who depend on accurate prompts to buckle up.

The preliminary evaluation covers approximately 142,572 model year 2023 and 2024 Honda Pilot vehicles, following reports that seatbelt indicators were providing false information for both second- and third-row seats. According to an ODI report (PDF), the investigation was launched after at least six consumer complaints alleging faulty rear seatbelt warnings were received.

Loss of Motive Power Investigation

A third investigation was launched on October 28 into approximately 124,795 model year 2020 through 2022 Honda CR-V Hybrid vehicles, after federal regulators received at least 48 owner reports describing intermittent loss of power while driving, a defect that could increase the risk of a crash. 

The ODI resume (PDF) reports that the loss of motive power occurs without warning at highway speeds and is accompanied by a flashing check engine light immediately beforehand.

Motive power can be restored by turning the ignition off and back on. However, this also clears the check engine light and any fault codes that were set. 

The intermittent nature of this fault, combined with the absence of fault codes, often leads to multiple visits to repair facilities without any successful repairs.

Sign up for more safety and legal news that could affect you or your family.

Written By: Darian Hauf

Consumer Safety & Recall News Writer

Darian Hauf is a consumer safety writer at AboutLawsuits.com, where she covers product recalls, public health alerts, and regulatory updates from agencies like the FDA and CPSC. She contributes research and reporting support on emerging safety concerns affecting households and consumers nationwide.



1 Comments


Becky
Mark sarted Keytruda therapy Feb 27, 2025 and had 2 more doses every 21 days, March 20, 2025 and April 10, 2025. Hospitalized 3/12/25 syncope and severe hypotension. Hypotension continued after discharge. Hospitalized April 13, 2025, airlifted to Penrose Hospital Colorado Springs. Diagnosed with Hemorrhagic Stroke. Neurologist stated the stroke was potentially related to Keytruda. Discharged 4/17/25. Transported by ambulance April 12, 2025 and admitted to San Juan Regional Medical center with diagnoses of DKA, Hyperglycemia (BS 968), Acidosis and A. Fib with RVR, all considered side effects of Keytruda. Mark still struggles with some cognitive issues and is a brittle insulin dependent diabetic. It is necessary to travel approximately 400 miles to see medical specialists.

This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

A tabletop fire pit lawsuit claims a Rhode Island man suffered catastrophic burn injuries this summer due to manufacturers ignoring safety warnings by federal regulators.
A federal judge has scheduled a series of case management conferences throughout 2026 as the parties prepare for five “pilot” bellwether trials, which are expected to begin in late 2026 or early 2027.